These immune populations are known to modulate inflammation, bone resorption and remodelling, reinforcing the immunomodulatory relevance of FMO4, PSMA4 and VEGFA in osteoporosis pathophysiology. This evidence concerns the gene PSMA4 and osteoporosis.